Skip to Main Content

The (POGO) Blog

November 22, 2017

By Daniel Van Schooten

Food Fight: Fighting for Food Safety Without a Champion



Thanksgiving dinner As you get ready to feast on turkey this Thanksgiving, one thing you can be thankful for is the U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS).

Continue Reading Food Fight: Fighting for Food Safety Without a Champion

Topics: Government Accountability, Public Health and Science

April 3, 2017

By David S. Hilzenrath

Questions for Trump’s FDA Nominee



Scott Gottlieb President Donald Trump’s nominee to head the Food and Drug Administration has deep roots in the pharmaceutical industry he would oversee.

Continue Reading Questions for Trump’s FDA Nominee

Topics: Public Health and Science

March 3, 2017

By David S. Hilzenrath

Trump’s Dangerous Prescription for the FDA



President Trump addressing a joint session of Congress, with VP Mike Pence and Rep. Paul Ryan seated behind him, clapping. President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.

Continue Reading Trump’s Dangerous Prescription for the FDA

Topics: Government Accountability, Open Government, Public Health and Science

August 12, 2016

By David S. Hilzenrath

UPDATE: DOJ Subpoenas Maker of Faulty Blood Testing Devices Spotlighted by POGO



Picture of a drop of blood on thumb. Alere Inc., maker of faulty INRatio blood testing devices, said it has received a Justice Department subpoena for records related to the devices’ accuracy and “interactions with the FDA.”

Continue Reading UPDATE: DOJ Subpoenas Maker of Faulty Blood Testing Devices Spotlighted by POGO

Topics: Government Accountability, Public Health and Science

July 13, 2016

By David S. Hilzenrath

FDA Says Faulty Devices Had "Minimal" Impact on Trial Led by New Boss



Picture of a drop of blood on thumb. The FDA said faulty INRatio blood testing devices had “minimal” impact on a clinical trial of blood thinner Xarelto that FDA head Robert Califf co-chaired.

Continue Reading FDA Says Faulty Devices Had "Minimal" Impact on Trial Led by New Boss

Topics: Government Accountability, Public Health and Science

Items 1 - 5 of 27  123456Next

Browse POGOBlog by Topic

POGO on Facebook

POGOBlog Contributors

See All Blog Contributors